These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 220530)

  • 21. [Myasthenia gravis. Prototype of an anti-receptor autoaggression disease (author's transl)].
    Hohlfeld R; Wekerle H
    MMW Munch Med Wochenschr; 1981 Jul; 123(31):1207-11. PubMed ID: 6790965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Physiopathology of myasthenia gravis. A review (author's transl)].
    Bergmans J
    Ann Chir; 1980 Mar; 34(3):147-57. PubMed ID: 6245616
    [No Abstract]   [Full Text] [Related]  

  • 23. Facilitatory effects of 4-aminopyridine on neuromuscular transmission in disease states.
    Kim YI; Goldner MM; Sanders DB
    Muscle Nerve; 1980; 3(2):112-9. PubMed ID: 6245355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pathogenesis of myasthenia gravis.
    Heilbronn E; Stålberg E
    J Neurochem; 1978 Jul; 31(1):5-11. PubMed ID: 209148
    [No Abstract]   [Full Text] [Related]  

  • 25. Disorders of neuromuscular transmission: a review.
    Daube JR
    Arch Phys Med Rehabil; 1983 May; 64(5):195-200. PubMed ID: 6303269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Geoepidemiology of myasthenia gravis [corrected].
    Meyer A; Levy Y
    Autoimmun Rev; 2010 Mar; 9(5):A383-6. PubMed ID: 19922815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunobiology of myasthenia gravis, experimental autoimmune myasthenia gravis, and Lambert-Eaton syndrome.
    Lindstrom J
    Annu Rev Immunol; 1985; 3():109-31. PubMed ID: 2998417
    [No Abstract]   [Full Text] [Related]  

  • 28. Pathophysiology of myasthenia gravis.
    Hughes BW; Moro De Casillas ML; Kaminski HJ
    Semin Neurol; 2004 Mar; 24(1):21-30. PubMed ID: 15229789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro.
    Burges J; Wray DW; Pizzighella S; Hall Z; Vincent A
    Muscle Nerve; 1990 May; 13(5):407-13. PubMed ID: 2345558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immunopathology of myasthenia gravis.
    Engel AG
    Int J Neurol; 1980; 14(1):35-46. PubMed ID: 6293990
    [No Abstract]   [Full Text] [Related]  

  • 31. A non-immunogenic myasthenia gravis model and its application in a study of transsynaptic regulation at the neuromuscular junction.
    Molenaar PC; Oen BS; Plomp JJ; Van Kempen GT; Jennekens FG; Hesselmans LF
    Eur J Pharmacol; 1991 Apr; 196(1):93-101. PubMed ID: 1874282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Myasthenia, a model of a disease caused by auto-antibodies].
    Goulon M; Gajdos P; Goulon-Goëau C
    Ann Med Interne (Paris); 1987; 138(6):444-61. PubMed ID: 2829682
    [No Abstract]   [Full Text] [Related]  

  • 33. Chronic experimental autoimmune myasthenia gravis induced by monoclonal antibody to acetylcholine receptor: biochemical and electrophysiologic criteria.
    Gomez CM; Richman DP
    J Immunol; 1987 Jul; 139(1):73-6. PubMed ID: 3035025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune myasthenia gravis in childhood.
    Andrews PI
    Semin Neurol; 2004 Mar; 24(1):101-10. PubMed ID: 15229797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunologic aspects of disorders of neuromuscular transmission. 1. Myasthenia gravis].
    Andreis I; Lovnicki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):154-8. PubMed ID: 7968204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homeostatic synaptic plasticity at the neuromuscular junction in myasthenia gravis.
    Wang X; Rich MM
    Ann N Y Acad Sci; 2018 Jan; 1412(1):170-177. PubMed ID: 28981978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.
    Meinl E; Klinkert WE; Wekerle H
    Am J Pathol; 1991 Nov; 139(5):995-1008. PubMed ID: 1951638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The neuromuscular junction: recent developments.
    Bowman WC
    Eur J Anaesthesiol; 1985 Mar; 2(1):59-93. PubMed ID: 2410263
    [No Abstract]   [Full Text] [Related]  

  • 39. Experimental myasthenia: lack of correlation between the autoantibody titer and the reduction of acetylcholine-controlled ionic channels measured at functioning endplates.
    Hohlfeld R; Sterz R; Kalies I; Wekerle H; Peper K
    Muscle Nerve; 1983 Feb; 6(2):160-3. PubMed ID: 6304508
    [No Abstract]   [Full Text] [Related]  

  • 40. [Ultrastructural study on the muscle end-plates in a case of myasthenia gravis].
    Tu LH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1987 Oct; 20(5):273-5. PubMed ID: 3450483
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.